text.skipToContent text.skipToNavigation

Immunosuppressant (IPT)

daps UKAS Logo
  • UKAS accredited proficiency testing scheme
  • The LGC Immunosuppressant proficiency testing scheme provides independent performance assessment for laboratories performing quantification of immunosuppressant drugs in blood and plasma.
  • Immunosuppressant drugs are a class of drugs that suppress, or reduce, the strength of the body’s immune system.
    In addition to being used to prevent organ rejection, they are often used to treat autoimmune disorders such as lupus, psoriasis, and rheumatoid arthritis.
  • Regular blood tests are essential for monitoring therapeutic levels and whether dosage changes are needed.
  • To successfully make these informed decisions laboratories need to demonstrate that drug measurements are reliable, reproducible and accurate.
  • The operation of the LGC IPT scheme is supported by an Advisory Group consisting of members of the professional bodies, scheme participants, and others experienced in the field
  • The scheme reports on the performance of U.K. participants (who have clinical responsibilities) to the National Quality Assurance Advisory Panels for Chemical Pathology.
  • Scheme operates from January to December



Round dates


Despatch Date

Reporting Deadline

IP41814 Jan 201911 Feb 2019
IP41911 Feb 201911 Mar 2019
IP42011 Mar 201908 Apr 2019
IP42108 Apr 201907 May 2019
IP42213 May 201910 Jun 2019
IP42310 Jun 201908 Jul 2019
IP42408 Jul 201905 Aug 2018
IP42512 Aug 201909 Sep 2019
IP42609 Sep 201907 Oct 2019
IP42714 Oct 201911 Nov 2019
IP42811 Nov 201909 Dec 2019
IP42909 Dec 201906 Jan 2020



PT online reporting


PT certification & accreditation


Order PT now



Punchout session timeout warning

Your punchout session will expire in 1 min 59 sec.

Select "Continue session" to extend your session.